Type-2 diabetes: Current understanding and future perspectives
- PMID: 26177573
- DOI: 10.1002/iub.1396
Type-2 diabetes: Current understanding and future perspectives
Abstract
The rapid outbreak of type-2 diabetes is one of the largest public health problems around the globe. Particularly, the developing nations are becoming the epicenters of cardiometabolic disorders owing to the change in lifestyle and diet preference besides genetic predisposition. Diabetes has become a major independent risk factor for cardiovascular diseases in South Asian countries including India. The pathogenesis of type-2 diabetes primarily initiates with inadequacy of pancreatic islet β-cells to respond to chronic fuel surfeit and hence causing glycemic load, insulin resistance, and obesity. Urban Indian life is threatened with unhealthy high calorie diet and sedentary habits, and thus impairing the metabolic status of "thin-fat Indians" and rendering them more vulnerable to metabolic disorders. Furthermore, the metabolic dysfunction may be triggered off quite early in life due to poor maternal health and impairment in intrauterine programming and, particularly in rural India. The impaired fetal development affects the health status in later stage of life by promoting obesity, insulin resistance, type-2 diabetes, and cardiovascular complications. Therefore, the preventive and therapeutic approaches focus on a holistic strategy to improve maternal and child health, promote balanced diet and physical exercise in combination with pharmacological intervention of reducing/checking hyperglycemia, obesity, and cardiovascular complications. This review summarizes the epidemiology, mechanisms, and risk factors for diabetes and cardiovascular disorders with a focus on the Indian subcontinent.
Keywords: dyslipidemia; insulin resistance; intrauterine programming; obesity; thrifty phenotype and inflammation; type-2 diabetes.
© 2015 International Union of Biochemistry and Molecular Biology.
Similar articles
-
The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.Metab Syndr Relat Disord. 2009 Dec;7(6):497-514. doi: 10.1089/met.2009.0024. Metab Syndr Relat Disord. 2009. PMID: 19900153 Review.
-
Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes.J Cardiovasc Risk. 1997 Jun;4(3):201-8. J Cardiovasc Risk. 1997. PMID: 9475675 Review.
-
Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life.Med Wieku Rozwoj. 2011 Jul-Sep;15(3):203-15. Med Wieku Rozwoj. 2011. PMID: 22006475 Review.
-
Early life origins of insulin resistance and type 2 diabetes in India and other Asian countries.J Nutr. 2004 Jan;134(1):205-10. doi: 10.1093/jn/134.1.205. J Nutr. 2004. PMID: 14704320 Review.
-
The thrifty 'catch-up fat' phenotype: its impact on insulin sensitivity during growth trajectories to obesity and metabolic syndrome.Int J Obes (Lond). 2006 Dec;30 Suppl 4:S23-35. doi: 10.1038/sj.ijo.0803516. Int J Obes (Lond). 2006. PMID: 17133232
Cited by
-
Development and validation of nomograms for predicting cardiovascular disease risk in patients with prediabetes and diabetes.Sci Rep. 2024 Sep 8;14(1):20909. doi: 10.1038/s41598-024-71904-3. Sci Rep. 2024. PMID: 39245747 Free PMC article.
-
Current views on selenoprotein S in the pathophysiological processes of diabetes-induced atherosclerosis: potential therapeutics and underlying biomarkers.Diabetol Metab Syndr. 2024 Jan 3;16(1):5. doi: 10.1186/s13098-023-01247-y. Diabetol Metab Syndr. 2024. PMID: 38172976 Free PMC article. Review.
-
Association of gastric inhibitory polypeptide receptor (GIPR) gene polymorphism with type 2 diabetes mellitus in iranian patients.BMC Med Genomics. 2023 Mar 7;16(1):44. doi: 10.1186/s12920-023-01477-z. BMC Med Genomics. 2023. PMID: 36882778 Free PMC article.
-
NMR-Based Metabolomic Approach Tracks Potential Serum Biomarkers of Disease Progression in Patients with Type 2 Diabetes Mellitus.J Clin Med. 2019 May 21;8(5):720. doi: 10.3390/jcm8050720. J Clin Med. 2019. PMID: 31117294 Free PMC article.
-
Effect of dapagliflozin on diabetic patients with cardiovascular disease via MAPK signalling pathway.J Cell Mol Med. 2021 Aug;25(15):7500-7512. doi: 10.1111/jcmm.16786. Epub 2021 Jul 14. J Cell Mol Med. 2021. PMID: 34258872 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical